APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injections for SMA

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Injections for SMA Market Outlook and Growth Opportunities 2026

29 December 2025192 pages

Choose your research edition.

Industry ResearchInjections for SMA Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Injections for SMA Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Injections for SMA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injections for SMA Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Injections for SMA Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Injections for SMA market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Injections for SMA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Injections for SMA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injections for SMA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Injections for SMA market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Injections for SMA market include Novartis, Biogen and Ionis Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Injections for SMA market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Injections for SMA and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Injections for SMA sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injections for SMA market size, projected growth trends, production technologies, key applications, and end-use industries.

Injections for SMA Segment by Company

Novartis

Biogen

Ionis Pharmaceuticals

Injections for SMA Segment by Type

Antisense Oligonucleotides

Gene Therapy

Injections for SMA Segment by Application

Hospital

Clinic

Other

Injections for SMA Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Injections for SMA status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Injections for SMA market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Injections for SMA significant trends, drivers, influence factors in global and regions.

6. To analyze Injections for SMA competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injections for SMA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injections for SMA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injections for SMA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injections for SMA market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Injections for SMA industry.

Chapter 3: Detailed analysis of Injections for SMA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Injections for SMA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Injections for SMA in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Injections for SMA Industry Trends Table 2. Injections for SMA Industry Drivers Table 3. Injections for SMA Industry Opportunities and Challenges Table 4. Injections for SMA Industry Restraints Table 5. Global Injections for SMA Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Injections for SMA Revenue Share by Company (2021-2026) Table 7. Global Injections for SMA Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Injections for SMA Sales Volume Share by Company (2021-2026) Table 9. Global Injections for SMA Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Injections for SMA Company Ranking, (2024-2026) & (USD Million) Table 11. Global Injections for SMA Key Company Manufacturing Base & Headquarters Table 12. Global Injections for SMA Company, Product Type & Application Table 13. Global Injections for SMA Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Injections for SMA by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antisense Oligonucleotides Table 18. Significant Companies of Gene Therapy Table 19. Global Injections for SMA Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Injections for SMA Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Injections for SMA Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Injections for SMA Sales Volume Share by Type (2021-2026) Table 23. Global Injections for SMA Sales Volume Share by Type (2027-2032) Table 24. Global Injections for SMA Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Injections for SMA Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Injections for SMA Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Injections for SMA Sales Value Share by Type (2021-2026) Table 28. Global Injections for SMA Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Injections for SMA Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Injections for SMA Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Injections for SMA Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Injections for SMA Sales Volume Share by Application (2021-2026) Table 36. Global Injections for SMA Sales Volume Share by Application (2027-2032) Table 37. Global Injections for SMA Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Injections for SMA Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Injections for SMA Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Injections for SMA Sales Value Share by Application (2021-2026) Table 41. Global Injections for SMA Sales Value Share by Application (2027-2032) Table 42. Global Injections for SMA Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Injections for SMA Sales by Region (2021-2026) & (K Units) Table 44. Global Injections for SMA Sales Market Share by Region (2021-2026) Table 45. Global Injections for SMA Sales by Region (2027-2032) & (K Units) Table 46. Global Injections for SMA Sales Market Share by Region (2027-2032) Table 47. Global Injections for SMA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Injections for SMA Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Injections for SMA Sales Value Share by Region (2021-2026) Table 50. Global Injections for SMA Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Injections for SMA Sales Value Share by Region (2027-2032) Table 52. Global Injections for SMA Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Injections for SMA Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Injections for SMA Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Injections for SMA Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Injections for SMA Sales by Country (2021-2026) & (K Units) Table 57. Global Injections for SMA Sales Market Share by Country (2021-2026) Table 58. Global Injections for SMA Sales by Country (2027-2032) & (K Units) Table 59. Global Injections for SMA Sales Market Share by Country (2027-2032) Table 60. Global Injections for SMA Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Injections for SMA Sales Value Market Share by Country (2021-2026) Table 62. Global Injections for SMA Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Injections for SMA Sales Value Market Share by Country (2027-2032) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Injections for SMA Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Novartis Injections for SMA Product Portfolio Table 68. Novartis Recent Development Table 69. Biogen Company Information Table 70. Biogen Business Overview Table 71. Biogen Injections for SMA Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Biogen Injections for SMA Product Portfolio Table 73. Biogen Recent Development Table 74. Ionis Pharmaceuticals Company Information Table 75. Ionis Pharmaceuticals Business Overview Table 76. Ionis Pharmaceuticals Injections for SMA Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Ionis Pharmaceuticals Injections for SMA Product Portfolio Table 78. Ionis Pharmaceuticals Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Injections for SMA Distributors List Table 82. Injections for SMA Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Injections for SMA Product Image Figure 2. Global Injections for SMA Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injections for SMA Sales Value (2021-2032) & (US$ Million) Figure 4. Global Injections for SMA Sales (2021-2032) & (K Units) Figure 5. Global Injections for SMA Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Injections for SMA Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antisense Oligonucleotides Image Figure 10. Gene Therapy Image Figure 11. Global Injections for SMA Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Injections for SMA Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Injections for SMA Sales Volume Share by Type (2021-2032) Figure 14. Global Injections for SMA Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Injections for SMA Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Injections for SMA Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Injections for SMA Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Injections for SMA Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Injections for SMA Sales Volume Share by Application (2021-2032) Figure 23. Global Injections for SMA Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Injections for SMA Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Injections for SMA Sales Value Share by Application (2021-2032) Figure 26. Global Injections for SMA Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Injections for SMA Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Injections for SMA Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Injections for SMA Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Injections for SMA Sales Value (2021-2032) & (US$ Million) Figure 31. North America Injections for SMA Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Injections for SMA Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Injections for SMA Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Injections for SMA Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Injections for SMA Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Injections for SMA Sales Value (2021-2032) & (US$ Million) Figure 37. South America Injections for SMA Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Injections for SMA Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Injections for SMA Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Injections for SMA Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Injections for SMA Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Injections for SMA Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Injections for SMA Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Injections for SMA Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Antisense Oligonucleotides
  • Gene Therapy
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novartis
  • Biogen
  • Ionis Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Injections for SMA Sales Value (2021-2032)
  4. 1.2.2 Global Injections for SMA Sales Volume (2021-2032)
  5. 1.2.3 Global Injections for SMA Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Injections for SMA Market Dynamics
  1. 2.1 Injections for SMA Industry Trends
  2. 2.2 Injections for SMA Industry Drivers
  3. 2.3 Injections for SMA Industry Opportunities and Challenges
  4. 2.4 Injections for SMA Industry Restraints
3 Injections for SMA Market by Company
  1. 3.1 Global Injections for SMA Company Revenue Ranking in 2025
  2. 3.2 Global Injections for SMA Revenue by Company (2021-2026)
  3. 3.3 Global Injections for SMA Sales Volume by Company (2021-2026)
  4. 3.4 Global Injections for SMA Average Price by Company (2021-2026)
  5. 3.5 Global Injections for SMA Company Ranking (2024-2026)
  6. 3.6 Global Injections for SMA Company Manufacturing Base and Headquarters
  7. 3.7 Global Injections for SMA Company Product Type and Application
  8. 3.8 Global Injections for SMA Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Injections for SMA Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Injections for SMA Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Injections for SMA Market by Type
  1. 4.1 Injections for SMA Type Introduction
  2. 4.1.1 Antisense Oligonucleotides
  3. 4.1.2 Gene Therapy
  4. 4.2 Global Injections for SMA Sales Volume by Type
  5. 4.2.1 Global Injections for SMA Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Injections for SMA Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Injections for SMA Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Injections for SMA Sales Value by Type
  9. 4.3.1 Global Injections for SMA Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Injections for SMA Sales Value by Type (2021-2032)
  11. 4.3.3 Global Injections for SMA Sales Value Share by Type (2021-2032)
5 Injections for SMA Market by Application
  1. 5.1 Injections for SMA Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Injections for SMA Sales Volume by Application
  6. 5.2.1 Global Injections for SMA Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Injections for SMA Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Injections for SMA Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Injections for SMA Sales Value by Application
  10. 5.3.1 Global Injections for SMA Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Injections for SMA Sales Value by Application (2021-2032)
  12. 5.3.3 Global Injections for SMA Sales Value Share by Application (2021-2032)
6 Injections for SMA Regional Sales and Value Analysis
  1. 6.1 Global Injections for SMA Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Injections for SMA Sales by Region (2021-2032)
  3. 6.2.1 Global Injections for SMA Sales by Region: 2021-2026
  4. 6.2.2 Global Injections for SMA Sales by Region (2027-2032)
  5. 6.3 Global Injections for SMA Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Injections for SMA Sales Value by Region (2021-2032)
  7. 6.4.1 Global Injections for SMA Sales Value by Region: 2021-2026
  8. 6.4.2 Global Injections for SMA Sales Value by Region (2027-2032)
  9. 6.5 Global Injections for SMA Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Injections for SMA Sales Value (2021-2032)
  12. 6.6.2 North America Injections for SMA Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Injections for SMA Sales Value (2021-2032)
  15. 6.7.2 Europe Injections for SMA Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Injections for SMA Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Injections for SMA Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Injections for SMA Sales Value (2021-2032)
  21. 6.9.2 South America Injections for SMA Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Injections for SMA Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Injections for SMA Sales Value Share by Country, 2025 VS 2032
7 Injections for SMA Country-level Sales and Value Analysis
  1. 7.1 Global Injections for SMA Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Injections for SMA Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Injections for SMA Sales by Country (2021-2032)
  4. 7.3.1 Global Injections for SMA Sales by Country (2021-2026)
  5. 7.3.2 Global Injections for SMA Sales by Country (2027-2032)
  6. 7.4 Global Injections for SMA Sales Value by Country (2021-2032)
  7. 7.4.1 Global Injections for SMA Sales Value by Country (2021-2026)
  8. 7.4.2 Global Injections for SMA Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Injections for SMA Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Injections for SMA Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Injections for SMA Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Injections for SMA Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Injections for SMA Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Injections for SMA Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Injections for SMA Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Injections for SMA Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Injections for SMA Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Injections for SMA Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Injections for SMA Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Injections for SMA Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Injections for SMA Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Injections for SMA Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Injections for SMA Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Injections for SMA Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Injections for SMA Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Injections for SMA Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Injections for SMA Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Injections for SMA Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Injections for SMA Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Injections for SMA Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Injections for SMA Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Injections for SMA Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Injections for SMA Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Injections for SMA Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Injections for SMA Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Injections for SMA Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Injections for SMA Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Injections for SMA Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Injections for SMA Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Injections for SMA Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Injections for SMA Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Injections for SMA Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Injections for SMA Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Injections for SMA Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Injections for SMA Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Injections for SMA Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Injections for SMA Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Injections for SMA Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Injections for SMA Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Injections for SMA Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Injections for SMA Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Injections for SMA Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Injections for SMA Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Injections for SMA Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Injections for SMA Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Injections for SMA Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Injections for SMA Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Injections for SMA Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Injections for SMA Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Injections for SMA Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Injections for SMA Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Injections for SMA Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Injections for SMA Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Injections for SMA Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Injections for SMA Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Injections for SMA Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Injections for SMA Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Injections for SMA Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Injections for SMA Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Injections for SMA Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Injections for SMA Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Injections for SMA Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Injections for SMA Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Injections for SMA Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Injections for SMA Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Injections for SMA Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Injections for SMA Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Injections for SMA Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Injections for SMA Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Injections for SMA Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Injections for SMA Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Injections for SMA Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Injections for SMA Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Injections for SMA Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Injections for SMA Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Injections for SMA Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Injections for SMA Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Injections for SMA Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Injections for SMA Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Injections for SMA Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Injections for SMA Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Injections for SMA Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Injections for SMA Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Injections for SMA Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Biogen
  8. 8.2.1 Biogen Company Information
  9. 8.2.2 Biogen Business Overview
  10. 8.2.3 Biogen Injections for SMA Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Biogen Injections for SMA Product Portfolio
  12. 8.2.5 Biogen Recent Developments
  13. 8.3 Ionis Pharmaceuticals
  14. 8.3.1 Ionis Pharmaceuticals Company Information
  15. 8.3.2 Ionis Pharmaceuticals Business Overview
  16. 8.3.3 Ionis Pharmaceuticals Injections for SMA Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ionis Pharmaceuticals Injections for SMA Product Portfolio
  18. 8.3.5 Ionis Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Injections for SMA Value Chain Analysis
  2. 9.1.1 Injections for SMA Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Injections for SMA Sales Mode & Process
  6. 9.2 Injections for SMA Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Injections for SMA Distributors
  9. 9.2.3 Injections for SMA Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst